Ketamine ameliorates depressive-like behaviors and immune alterations in adult rats following maternal deprivation

Neuroscience Letters

Volumn 584, Issue , 2015, Pages 83-87

  Réus, Gislaine Z ^a,b   Nacif, Marcos Paulo ^b   Abelaira, Helena M ^b   Tomaz, Débora B ^b   dos Santos, Maria Augusta B ^b   Carlessi, Anelise S ^b   da Luz, Jaine R ^a   Gonçalves, Renata C ^a   Vuolo, Francieli ^a   Dal Pizzol, Felipe ^a   Carvalho, André F ^c   Quevedo, João ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Depression; Immune system; Ketamine; NMDA receptor

Indexed keywords

GLUTAMIC ACID; INTERLEUKIN 1; INTERLEUKIN 6; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; ANTIDEPRESSANT AGENT; CYTOKINE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FEMALE; IMMOBILIZATION; IMMUNE STATUS; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; MALE; MATERNAL DEPRIVATION; NONHUMAN; RAT; ANIMAL; BLOOD; CEREBROSPINAL FLUID; IMMUNOLOGY; PSYCHOLOGY; WISTAR RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; CYTOKINES; DEPRESSION; FEMALE; INTERLEUKIN-1; INTERLEUKIN-6; KETAMINE; MALE; MATERNAL DEPRIVATION; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84908637423     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.10.022     Document Type: Article

References (47)

1. Kessler R.C., Wang O.S. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu. Rev. Public Health 2008, 29:115-129.
2. Nakajima S., Suzuki T., Watanabe K., Kashima H., Uchida H. Accelerating response to antidepressant treatment in depression: a review and clinical suggestions. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34:259-264.
3. Réus G.Z., Stringari R.B., Ribeiro K.F., Cipriano A.L., Panizzutti B.S., Stertz L., Lersch C., Kapczinski F., Quevedo J. Maternal deprivation induces depressive-like behaviour and alters neurotrophin levels in the rat brain. Neurochem. Res. 2011, 36:460-466.
4. Duman R.S., Li N., Liu R., Duric V., Aghajanian G. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology 2012, 62:35-41.
5. Tokita K., Yamaji T., Hashimoto K. Roles of glutamate signaling in preclinical and/or mechanistic models of depression. Pharmacol. Biochem. Behav. 2012, 100:604-688.
6. Goswami D.B., Jernigan C.S., Chandran A., Iyo A.H., May W.L., Austin M.C., Stockmeier C.A., Karolewicz B. Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 43:126-133.
7. Réus G.Z., Dos Santos M.A., Abelaira H.M., Ribeiro K.F., Petronilho F., Vuolo F., Colpo G.D., Pfaffenseller B., Kapczinski F., Dal-Pizzol F., Quevedo J. Imipramine reverses alterations in cytokines and BDNF levels induced by maternal deprivation in adult rats. Behav. Brain Res. 2013, 242:40-46.
8. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., Krystal J.H., Mason G.F. Subtypespecific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 2004, 61:705-713.
9. Mitani H., Shirayama Y., Yamada T., Maeda K., Ashby C.R., Kawahara R. Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:1155-1158.
10. Garcia L.S., Comim C.M., Valvassori S.S., Réus G.Z., Barbosa L.M., Andreazza A.C., Stertz L., Fries G.R., Gavioli E.C., Kapczinski F., Quevedo J. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:140-144.
11. Garcia L.S., Comim C.M., Valvassori S.S., Réus G.Z., Andreazza A.C., Stertz L., Fries G.R., Gavioli E.C., Kapczinski F., Quevedo J. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels. Basic Clin. Pharmacol. Toxicol. 2008, 103:502-506.
12. Duman R.S., Aghajanian G.K. Synaptic dysfunction in depression: potential therapeutic targets. Science 2012, 338:68-72.
13. Gosek P., Chojnacka M., Bieńkowski P., Swiecicki L. Antidepressant effect of ketamine, a N-methyl-d-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression. Psychiatr. Pol. 2012, 46:283-294.
14. Chandran A., Iyo A.H., Jernigan C.S., Legutko B., Austin M.C., Karolewicz B. Reduced phosphorylation of the mTOR signaling pathway components in the amygdala of rats exposed to chronic stress. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 40:240-245.
15. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 2005, 10:900-919.
16. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuro Endocrinol. Lett. 2009, 30:715-722.
17. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 2012, 36:764-785.
18. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:201-217.
19. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
20. Mossner R., Mikova O., Koutsilieri E., Saoud M., Ehlis A.C., Müller N., Fallgatter A.J., Riederer P. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J. Biol. Psychiatry 2007, 8:141-174.
21. Basterzi A.D., Aydemir C., Kisa C., Aksaray S., Tuzer V., Yazici K., Göka E. IL-6 levels decrease SSRI treatment in patients with major depression. Hum. Psychopharmacol. 2005, 20:473-476.
22. O'Brien S.M., Scully P., Fitzgerald P., Scott L.V., Dinan T.G. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J. Psychiatr. Res. 2007, 41:326-331.
23. Matthews K., Robbins T.W. Early experience as a determinant of adult behavioural responses to reward: the effects of repeated maternal separation in the rat. Neurosci. Biobehav. Rev. 2003, 27:45-55.
24. Abelaira H.M., Réus G.Z., Quevedo J. Animal models as tools to study the pathophysiology of depression. Rev. Bras. Psiquiatr. 2013, 35:112-120.
25. Mello P.B. Physical exercise can reverse the deficit in fear memory induced by maternal deprivation. Neurobiol. Learn. Mem. 2009, 92:364-369.
26. Garcia L.S., Comim C.M., Valvassori S.S., Réus G.Z., Stertz L., Kapczinski F., Gavioli E.C., Quevedo J. Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:450-455.
27. Réus G.Z., Abelaira H.M., dos Santos M.A., Carlessi A.S., Tomaz D.B., Neotti M.V., Liranço J.L., Gubert C., Barth M., Kapczinski F., Quevedo J. Ketamine and imipramine in the nucleus accumbens regulate histone deacetylation induced by maternal deprivation and are critical for associated behaviors. Behav. Brain Res. 2013, 256:451-456.
28. Porsolt R.D., Le Pichon M., Jalfre M. Animal model of depression. Nature 1977, 730-732.
29. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
30. Agid O., Shapira B., Zislin J., Ritsner M., Hanin B., Murad H., Troudart T., Bloch M., Heresco-Levy U., Lerer B. Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol. Psychiatry 1999, 4:163-172.
31. Réus G.Z., Stringari R.B., Ribeiro K.F., Ferraro A.K., Vitto M.F., Cesconetto P., Souza C.T., Quevedo J. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav. Brain Res. 2011, 221:166-171.
32. Abelaira H.M., Réus G.Z., Ribeiro K.F., Zappellini G., Cipriano A.L., Scaini G., Streck E.L., Quevedo J. Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats. Pharmacol. Biochem. Behav. 2012, 101:348-353.
33. Della F.P., Abelaira H.M., Réus G.Z., Dos Santos M.A., Tomaz D.B., Antunes A.R., Scaini G., Morais M.O., Streck E.L., Quevedo J. Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats. Metab. Brain Dis. 2013, 28:93-105.
34. Zarate C.A., Mathews D.C., Furey M.L. Human biomarkers of rapid antidepressant effects. Biol. Psychiatry 2013, 73:1142-1155.
35. Lowy M.T., Gault L., Yamamoto B.K. Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J. Neurochem. 1993, 61:1957-1960.
36. Sapolsky R.M., Stein-Behrens B.A., Armanini M.P. Long-term adrenalectomy causes loss of dentate gyrus and pyramidal neurons in the adult hippocampus. Exp. Neurol. 1991, 114:246-249.
37. Pickeringa C., Gustafsson L., Cebere A., Nylander I., Liljequist S. Repeated maternal separation of male Wistar rats alters glutamate receptor expression in the hippocampus but not the prefrontal cortex. Brain Res. 2006, 1099:101-108.
38. Hashimoto K., Sawa A., Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol. Psychiatry 2007, 62:1310-1316.
39. Küçükibrahimoglu E., Saygin M.Z., Caliskan M., Kaplan O.K., Unsal C., Gören M.Z. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram treated female patients with major depression. Eur. J. Clin. Pharmacol. 2009, 65:571-577.
40. Roman A., Rogóz Z., Kubera M., Nawrat D., Nalepa I. Concomitant administration of fluoxetine and amantadine modulates the activity of peritoneal macrophages of rats subjected to a forced swimming test. Pharmacol. Rep. 2009, 61:1069-1077.
41. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
42. Kubera M., Maes M., Budziszewska B., Basta-Kaim A., Leśkiewicz M., Grygier B., Rogóz Z., Lasoń W. Inhibitory effects of amantadine on the production of pro-inflammatory cytokines by stimulated in vitro human blood. Pharmacol. Rep. 2009, 61:1105-1112.
43. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol. Psychiatry 2008, 13:717-728.
44. Santello M., Volterra A. TNFα in synaptic function: switching gears. Trends Neurosci. 2012, 35:638-647.
45. Wu G., Chen T., Ueng Y., Chen R. Ketamine inhibits tumor necrosis factor-α and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Toxicol. Appl. Pharmacol. 2008, 228:105-113.
46. Yang C., Hong T., Shen J., Ding J., Dai X.W., Zhou Z.Q., Yang J.J. Ketamine exerts antidepressant effects and reduces IL-1β and IL-6 levels in rat prefrontal cortex and hippocampus. Exp. Ther. Med. 2013, 5:1093-1096.
47. Roytblat L., Talmor D., Rachinsky M., Greemberg L., Pekar A., Appelbaum A., Gurman G.M., Shapira Y., Duvdenani A. Ketamine attenuates the interleukin-6 response after cardiopulmonary bypass. Anesth. Analg. 1998, 87:266-271.